Lambda Antibody And Igm
Goat anti Human IgG and IgM (H&L) |
|||
GWB-6A792C | GenWay Biotech | 1 ml | Ask for price |
Human IgG antibody Laboratories manufactures the lambda antibody and igm reagents distributed by Genprice. The Lambda Antibody And Igm reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact igm antibody. Other Lambda products are available in stock. Specificity: Lambda Category: Antibody Group: And Igm
Human Anti centriole and centrosome antibody IgM ELISA kit |
||
BlueGene | 96T | 700 EUR |
Description: ELISA |
||
Rabbit IgG/IgM Antibody |
||
GenWay Biotech | 1 mg | Ask for price |
Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM |
||
Shanghai YL Biotech | 48T | 465 EUR |
Mouse phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM |
||
Shanghai YL Biotech | 96T | 600 EUR |
Salmon and Trout IgM ELISA |
||
Kamiya Biomedical Company | 96 tests | 595 EUR |
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
||
SunredBio | 96 tests | 528 EUR |
Description: A quantitative ELISA kit for measuring Human in samples from biological fluids. |
||
human phosphatidylinositol antibody IgG/IgM,PI Ab-IgG/IgM ELISA Kit |
||
ChemNorm | 96T | 577.2 EUR |
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161BTN-50UG | NSJ Bioreagents | 50ug | 347.65 EUR |
Description: This recombinant Mouse Lambda Light Chain antibody reacts to the lamda light chain of mouse immunoglobulins. No cross reactivity with the kappa light chain, human IgG, rat IgG, or goat IgG. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20161SAF-250UG | NSJ Bioreagents | 250ug | 832.15 EUR |
Description: This recombinant Mouse Lambda Light Chain antibody reacts to the lambda light chain of murine immunoglobulins. No cross reactivity with the kappa chain or human/rat/goat IgG. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179-100UG | NSJ Bioreagents | 100ug | 347.65 EUR |
Description: This recombinant Human Lambda Light Chain antibody reacts to the lambda light chain of human immunoglobulins. No cross reactivity with the kappa light chain or mouse/rat/goat IgG. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179BTN-50UG | NSJ Bioreagents | 50ug | 347.65 EUR |
Description: This recombinant Human Lambda Light Chain antibody reacts to the lambda light chain of human immunoglobulins. No cross reactivity with the kappa light chain, mouse IgG, rat IgG, or goat IgG |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
R20179SAF-250UG | NSJ Bioreagents | 250ug | 832.15 EUR |
Description: This recombinant Human Lambda Light Chain antibody reacts to the lambda light chain of human immunoglobulins. No cross reactivity with the kappa light chain or mouse/rat/goat IgG. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151CF488-100T | NSJ Bioreagents | 100 Tests | 349.3 EUR |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151IHC-7ML | NSJ Bioreagents | 7 ml | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3151SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3152SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261-20UG | NSJ Bioreagents | 20 ug | 153.3 EUR |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3261SAF-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
|||
Lambda Light Chain Antibody / Lambda Antibody |
|||
V3262-100UG | NSJ Bioreagents | 100 ug | 349.3 EUR |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |